CIK 0001583648
- Non-accelerated filer
- Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 300784346
- Phone
- +1 484-253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,071,070
- in 6 filings, $11.0M under 10b5-1 plans
Net −$11,071,070. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-24 | Yoder Stephen S. Chief Executive Officer | Grant or award · Stock Option (Right to buy) | +634,021 | 634,021 | ||
| 2022-02-22 | Yoder Stephen S. Chief Executive Officer | Grant or award · Stock Option (Right to buy) | +625,874 | 625,874 | ||
| 2021-03-04 | Yoder Stephen S. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +530,000 | 530,000 | ||
| 2020-02-27 | Yoder Stephen S. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +420,000 | 420,000 | ||
| 2019-02-26 | Yoder Stephen S. Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +380,000 | 380,000 | ||
| 2018-02-20 | Yoder Stephen S. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +325,000 | 325,000 | ||
| 2017-02-23 | Yoder Stephen S. Chief Executive Officer | Grant or award · Stock Option (Right to buy) | +434,350 | 434,350 | ||
| 2016-06-13 | Yoder Stephen S. President and CEO | Purchase | +6,000 | $1.68 | $10K | 6,000 |
| 2016-02-12 | Yoder Stephen S. President and CEO | Grant or award · Stock Option (right to buy) | +492,000 | 492,000 |
Page 1 of 1 · 9 trades